Research Article

Evidence for a Specific Diabetic Cardiomyopathy: An Observational Retrospective Echocardiographic Study in 656 Asymptomatic Type 2 Diabetic Patients

Table 1

Characteristics of the total cohort of type 2 diabetic patients, of those without hypertension and coronary artery disease, and of those with hypertension or coronary artery disease.

TotalWithout hypertension and CADWith hypertension or CAD
= 482

Age, years59.7 ± 8.756.7 ± 8.660.6 ± 8.6<0.0001
Gender (male/female)359/29795/62257/225NS
Diabetes duration, years13.7 ± 7.711.9 ± 7.214.2 ± 7.80.001
Body mass index, kg/m230.3 ± 6.128.5 ± 5.531.0 ± 6.2<0.0001
Body weight (kg)82.6 ± 16.878.0 ± 15.984.1 ± 16.8<0.0001
HbA1c, %8.7 ± 2.18.7 ± 2.08.7 ± 2.2NS
Retinopathy (%)242 (38.2)42 (27.1)192 (41.6)0.001
Nephropathy (%)256 (39.2)38 (24.2)210 (43.8)<0.0001
 Urinary albumin excretion rate, mg/day161 ± 50555 ± 205194 ± 567<0.05
 Creatinine clearance (mL/min)83 ± 2488 ± 1981 ± 25<0.01
Peripheral occlusive arterial disease (%)64 (10.1)10 (6.5)53 (11.4)0.09
Peripheral neuropathy (%)292 (45.0)65 (41.4)213 (44.8)NS
Silent myocardial ischemia (%)206 (31.4)26 (16.6)163 (33.8)<0.0001
CAD (%)71 (11.1)/71 (14.7)/
Hypertension (%)483 (73.6)/467 (96.9)/
 Antihypertensive therapy (%)437 (67.8)/423 (89.6)/
 Systolic blood pressure, mmHg135 ± 19125 ± 11138 ± 20<0.0001
 Diastolic blood pressure, mmHg75 ± 1171 ± 976 ± 11<0.0001
Dyslipidemia (%)445 (69.9)97 (64.2)334 (71.2)0.127
 Lipid-lowering treatment, %285 (44.4)48 (31.2)228 (48.3)<0.0001
 Total cholesterol, mmol/L5.1 ± 1.25.2 ± 1.05.0 ± 1.2<0.05
 HDL cholesterol, mmol/L1.2 ± 0.51.2 ± 0.41.2 ± 0.5NS
 LDL cholesterol, mmol/L3.0 ± 1.03.2 ± 0.92.9 ± 1.0<0.05
 Triglycerides, mmol/L1.9 ± 1.21.9 ± 1.11.9 ± 1.2NS
Smoking (%)142 (21.8)37 (23.7)104 (21.7)NS
Familial history of premature CAD (%)74 (11.5)16 (10.5)54 (11.4)NS

17 patients had silent myocardial ischemia but did not undergo a coronary angiography.
CAD: coronary artery disease; NS: nonsignificant ().
Data are mean ± SD or (%).